Methyl pyrazolo[1,5-a]pyrimidine-2-carboxylate, 97%, 1g

(2R,4R)-4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-1,2-PYRROLIDINEDICARBOXYLIC ACID 2-METHYL 1-(PHENYLMETHYL) ESTER, 95.0%, 1g

Single-channel microliter pipette Pipetman® G, 1000 to 5000 µl, P5000G, 1 piece

N-(4-methylpyridin-2-yl)ethane-1,2-diamine, 95.0%, 5g

1-[1-(4-fluorophenyl)cyclopropyl]methanamine hydrochloride, 98%, 1g

2,7-dimethyl[1,3]thiazolo[4,5-d]pyridazin-4(5H)-one, 95.0%, 1g

[acetoxy-(2,4,6-trimethylphenyl)-iodanyl] acetate, 5g

O-Acetyl-N-(tert-butyl)hydroxylamine hydrochloride, 95.0%, 1g

Pyrazolo[1,5-a]pyridine-3-carbonitrile, 96%, 500mg

6-Chloro-3-methoxypyridin-2-amine, 97%, 100mg

(R)-Methyl 2-(((benzyloxy)carbonyl)amino)but-3-enoate, 95.0%, 250mg

3,5-Dichlorothiophenol, 97.0%, 1g

Boc-4-amino-4-methyl-pentanoic acid, 99.0%, 100mg